Ultrafast Insulin Formulation May Enable Faster Management of Blood Sugar in Diabetes (1 of 2) (IMAGE)

American Association for the Advancement of Science (AAAS)

Ultrafast Insulin Formulation May Enable Faster Management of Blood Sugar in Diabetes (1 of 2)

Caption

The ultrafast-absorbing insulin is based on simpler insulin monomer molecules, which are absorbed far faster than the more complex dimers and hexamers used in commercial rapid-acting insulin analogs. This material relates to a paper that appeared in the Jul. 1, 2020, issue of Science Translational Medicine, published by AAAS. The paper, by J.L. Mann at Stanford University in Stanford, CA; and colleagues was titled, "An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients."

Credit

J.L. Mann et al., Science Translational Medicine (2020)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.